glp 1 taste change GLP-1s, and what's happening to our diets It is not just you.,

What is diagnostic FBG and A1c for prediabetes

For GLP-1 drugs, the risks include: Increased anxiety or panic from unstable blood sugar Triggering or worsening depression Heightened risk of obsessive eating behaviors Potential for self-esteem issues or body image dysmorphia For someone already struggling with mental health, these risks are compounded making proper medical oversight essential

In December 2025, Eli Lilly published the first positive Phase 3 readout for retatrutide (LY3437943), the triple-agonist peptide that had, until then, only been validated at Phase 2 scale

Daarom bouw je de medicatie stap voor stap op en is medische begeleiding belangrijk

Understanding the TRIUMPH-1 results is vital for evaluating Retatrutide's future role in medical weight loss